PedAM
Pediatric Disease Annotations & Medicines
| Disease | portal hypertension |
| Phenotype | C0040034|thrombocytopenia |
| Sentences | 6 |
| PubMedID- 20620520 | Background: thrombocytopenia typically resolves with resolution of portal hypertension after liver transplantation (lt) but persists in some patients. |
| PubMedID- 23150024 | This study was done to know the change in platelets count following early ligation of splenic artery during splenectomy in patients with thrombocytopenia due to portal hypertension with a hypothesis that splenic decongestion results in increased platelets count; thereby platelet transfusion can be avoided. |
| PubMedID- 23006937 | Conclusions: smaller-tumor tercile i patients had more advanced portal hypertension with thrombocytopenia than did larger-tumor patients. |
| PubMedID- 21757983 | The eligibility criteria for chemotherapy were as follows: (1) 18-75 years of age; (2) preserved liver function (pugh-child class a and b); (3) acceptable range of thrombocytopenia due to portal hypertension without any other causes of bone marrow suppression (platelet count>50,000/mm3 and leukocyte count>2,000/mm3); (4) normal serum creatinine (cr<1.2 mg/dl); (5) acceptable range of hepatitis activity (alanine aminotransferase, [alt]<100 iu/l); and (6) eastern cooperative oncology group performance status (ps) 0-2. the inclusion criteria of far advanced hcc features for the protocol were as follows: (1) tnm stage iii or iv by ajcc/uicc or lcsgj classification; (2) major vascular invasion, such as main portal vein tumor thrombosis or main hepatic vein tumor thrombosis; and (3) marked vascular shunts, such as avss or apss. |
| PubMedID- 22558526 | He had cirrhosis and thrombocytopenia with portal hypertension, possibly secondary to alcohol use. |
| PubMedID- 26203291 | The primary hemostasis provided by platelets is often reduced.52 thrombocytopenia due to portal hypertension and splenic sequestration often results in an increased bleeding risk. |
Page: 1